Synopsys CEO exercises options, sells 14.6K shares

Synopsys CEO Ghazi Sassine exercised 14,604 options and sold the resulting shares under a pre-arranged Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

SYNOPSYS INC (SNPS) reported that President and CEO Ghazi Sassine exercised stock options and sold the resulting shares on September 15, 2026. He exercised options for 14,604 shares of common stock at an exercise price of $135.88 per share, then sold 14,604 shares of common stock at a weighted average price of $374.8756 per share in multiple transactions. The options were originally exercisable from December 12, 2020 and are scheduled to expire on December 12, 2026, and after this transaction 14,604 options from this grant remained outstanding. All transactions were effected under a Rule 10b5-1 trading plan adopted on September 19, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 14,604 shares ($3.49M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Ghazi Sassine

Role PRESIDENT AND CEO

Sold 14,604 shs ($5.47M)

Approx. gross sale proceeds $5.47M

Approx. exercise cost $1.98M

Approx. pre-tax spread $3.49M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy) F2	14,604	$0.00	$0.00
Exercise	Common Stock	14,604	$135.88	$1.98M
Sale	Common Stock F1	14,604	$374.8756	$5.47M

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 14,604 contracts (Direct); Common Stock — 76,865 shares (Direct)

Footnotes (2)

1. F1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $371.995 to $379.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
2. F2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025.

Key Figures

Options exercised: 14,604 shares Option exercise price: $135.88 per share Shares sold: 14,604 shares +5 more

8 metrics

Options exercised 14,604 shares Options on Synopsys common stock exercised on September 15, 2026

Option exercise price $135.88 per share Exercise price for the 14,604 options exercised

Shares sold 14,604 shares Common shares sold on September 15, 2026

Weighted average sale price $374.8756 per share Average price for the 14,604 Synopsys shares sold

Sale price range $371.995–$379.990 per share Range of prices for the multiple sale transactions

Remaining options from grant 14,604 options Options remaining after the reported exercise

Option expiration date December 12, 2026 Scheduled expiration of the option grant involved

Rule 10b5-1 plan adoption date September 19, 2025 Date the trading plan governing these transactions was adopted

Key Terms

Non-Qualified Stock Option, weighted average sale price, Rule 10b5-1 trading plan

3 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

weighted average sale price financial

"Represents a weighted average sale price per share."

Rule 10b5-1 trading plan regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did SNPS CEO Ghazi Sassine report on September 15, 2026?

He exercised options for 14,604 shares of Synopsys common stock at $135.88 per share and sold 14,604 shares of common stock at a weighted average price of $374.8756 per share in multiple transactions.

At what prices did the SNPS shares sell in Ghazi Sassine’s September 2026 Form 4?

The reported sale covered 14,604 shares at a weighted average price of $374.8756 per share, with individual trades executed in a price range from $371.995 to $379.990 per share.

What was the option exercise price in the Synopsys (SNPS) CEO’s Form 4?

The options exercised by Ghazi Sassine on September 15, 2026 related to 14,604 shares of Synopsys common stock and carried an exercise price of $135.88 per share, based on an option that became exercisable on December 12, 2020.

Were the September 2026 SNPS insider transactions under a Rule 10b5-1 plan?

Yes. The filing states that the transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on September 19, 2025.

How many Synopsys options remained after Ghazi Sassine’s September 2026 exercise?

After the reported option exercise, the Form 4 shows 14,604 options from this particular grant remaining outstanding, with a scheduled expiration date of December 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:11 PM Accepted by SEC EDGAR 09/16/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ghazi Sassine

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CALIFORNIA 94085

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		M		14,604	A	$135.88	91,469	D
Common Stock	09/15/2026		S		14,604	D	$374.8756(1)	76,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$135.88	09/15/2026		M(2)			14,604	12/12/2020	12/12/2026	Common Stock	14,604	$0.0	14,604	D

Explanation of Responses:

1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $371.995 to $379.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025.

	By: POA pursuant Mary Lai For: Sassine E Ghazi	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)